Navidea Biopharmaceuticals (NAVB) is a biomedical company engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians. This stock closed up 4% to $3.10 on Tuesday.
Tuesday's Range: $2.95-$3.11
52-Week Range: $2.14-$4.77Volume: 904,000 Three-Month Average Volume: 634,622 From a technical perspective, NAVB ripped higher here right off some near-term support at $2.90 with above-average volume. This move is quickly pushing shares of NAVB within range of triggering a near-term breakout trade. That trade will hit if NAVB manages to clear its 200-day moving average of $3.13 with high volume. Traders should now look for long-biased trades in NAVB as long as it's trending above some key near-term support at $2.90 and then once it sustains a move or close above its 200-day at $3.13 with volume that hits near or above 634,622 shares. If that breakout triggers soon, then NAVB will set up to re-test or possibly take out its next major overhead resistance level at $3.37. Any high-volume move above $3.37 will then put NAVB within range of tagging its next major overhead resistance levels at $3.80 to $4.10. Trius Therapeutics Trius Therapeutics (TSRX) is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. This stock closed up 7.4% to $5.28 on Tuesday. Tuesday's Range: $4.96-$5.29 52-Week Range: $4.41-$6.49 Volume: 1.29 million Three-Month Average Volume: 382,453 From a technical perspective, TSRX soared higher here right off its 50-day moving average of $4.97 with monster upside volume. This move filled a previous gap down level from a few weeks ago that started at $5.20. Shares of TSRX are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if TSRX manages to clear its 200-day at $5.37 and then once it takes out more resistance at $5.60 with high volume. Traders should now look for long-biased trades in TSRX as long as it's trending above its 50-day at $4.97 and then once it sustains a move or close above those breakout levels with volume that hits near or above 382,453 shares. If that breakout hits soon, then TSRX will set up to re-test or possibly take out its next major overhead resistance levels at $5.90 to $5.93. Any move above those levels will then put $6.20 to $6.46 into focus for shares of TSRX.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV